Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-03

FDA Approved: ESTRADIOL AND NORETHINDRONE ACETATE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Ingenus Pharmaceuticals' Estradiol and norethindrone acetate as a generic product under ANDA210612.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL AND NORETHINDRONE ACETATE (ESTRADIOL AND NORETHINDRONE ACETATE)

Snippet

ORIG AP for ESTRADIOL AND NORETHINDRONE ACETATE (ESTRADIOL AND NORETHINDRONE ACETATE)